Evotec SE (EVO) EPS (Basic) Growth (1y) (2010 - 2025)
Evotec SE (EVO) EPS (Basic) Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.59% |
| Sep 30, 2025 | 15.90% |
| Dec 31, 2024 | -131.47% |
| Sep 30, 2024 | -239.82% |
| Dec 31, 2023 | 49.76% |
| Sep 30, 2023 | -11.15% |
| Jun 30, 2023 | 53.47% |
| Dec 31, 2022 | -168.60% |
| Sep 30, 2022 | -71.97% |
| Jun 30, 2022 | -138.36% |
| Mar 31, 2022 | -220.08% |
| Dec 31, 2021 | 2,942.56% |
| Sep 30, 2021 | 8,926.90% |
| Dec 31, 2020 | -82.76% |
| Jun 30, 2010 | 112.88% |
| Mar 31, 2010 | -106.21% |